Endocytic trafficking of CFTR in health and disease
- PMID: 17098482
- PMCID: PMC1964799
- DOI: 10.1016/j.jcf.2006.09.002
Endocytic trafficking of CFTR in health and disease
Abstract
The cystic fibrosis transmembrane conductance regulator (CFTR) is a Cl-selective anion channel expressed in epithelial tissues. Mutations in CFTR lead to the genetic disease cystic fibrosis (CF). Within each epithelial cell, CFTR interacts with a large number of transient macromolecular complexes, many of which are involved in the trafficking and targeting of CFTR. Understanding how these complexes regulate the trafficking and fate of CFTR, provides a singular insight not only into the patho-physiology of cystic fibrosis, but also provides potential drug targets to help cure this debilitating disease.
Figures


References
-
- Ulloa-Aguirre A, Janovick JA, Brothers SP, Conn PM. Pharmacologic Rescue of Conformationally-Defective Proteins: Implications for the treatment of human disease. Traffic. 2004;5:821–37. - PubMed
-
- Cohen FE, Kelly JW. Therapeutic approaches to protein-misfolding diseases. Nature. 2003;426:905–9. - PubMed
-
- Welsh MJ, Ramsey BW, Accurso F, Cutting GR. Cystic Fibrosis. In: Scriver CR, Beaudet AL, Valle D, editors. The metabolic and molecular basis of inherited disease. McGraw-Hill; New York: 2001. pp. 5121–88.
-
- Pilewski JM, Frizzell RA. Role of CFTR in airway disease. Physiol Rev. 1999;79:S215–55. - PubMed
-
- Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995;151:1075–82. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical